Precigen PGEN
NASDAQ PGEN
$6.80 -0.07 (-1.02%)
As of: Sep 9, 2026 · 3:59 PM EDT

Precigen (PGEN) Gross Profit (2013 - 2026)

Precigen's (PGEN) quarterly Gross Profit came in at $52.2 million in Q2 2026, up 22207.2% year-over-year from N/an in Q2 2025, and up 152.13% quarter-over-quarter from $20.7 million in Q1 2026.

Analysis

Precigen (PGEN) Gross Profit (2013 - 2026) Analysis & Trends

Precigen (PGEN) has reported Gross Profit for 14 consecutive years, with $52.2 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Gross Profit rose 22207.2% year-over-year to $52.2 million in Q2 2026; TTM through Jun 2026 was $77.7 million, a 259173.33% increase from a year earlier, with the FY2025 full-year figure at $4.9 million, up 1521.35% from the prior year.
  • Gross Profit was $52.2 million for Q2 2026 at Precigen, up from $20.7 million in the prior quarter.
  • Over five years, Gross Profit peaked at $52.2 million in Q2 2026 and troughed at -$297000.0 in Q2 2024.
  • A 5-year average of $5.4 million and a median of $282500.0 in 2023 frame the typical range for Gross Profit.
  • Across the five-year window, Gross Profit tumbled 524.29% in 2024 and surged 22207.2% in 2026, its largest moves.
  • Over 5 years, Gross Profit stood at $506000.0 in 2022, then tumbled by 125.69% to -$130000.0 in 2023, then soared by 116.15% to $21000.0 in 2024, then soared by 14038.1% to $3.0 million in 2025, then soared by 1657.26% to $52.2 million in 2026.
  • The last three Gross Profit figures came in at $52.2 million (Q2 2026), $20.7 million (Q1 2026), and $3.0 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Krystal Biotech 10.60 Bn 9.76 Bn 112.79 Mn
2 CRISPR Therapeutics AG 5.39 Bn 5.39 Bn -
3 Iovance Biotherapeutics 3.98 Bn 3.68 Bn 55.72 Mn
4 Legend Biotech 3.97 Bn 3.00 Bn 251.50 Mn
5 uniQure 3.09 Bn 3.09 Bn 5.49 Mn
6 Beam Therapeutics 3.06 Bn 3.06 Bn -
7 Precigen 2.54 Bn 2.54 Bn 52.17 Mn
8 Sarepta Therapeutics 2.38 Bn 1.58 Bn 251.87 Mn
9 Vericel 2.06 Bn 1.89 Bn 56.40 Mn
10 Taysha Gene Therapies 1.82 Bn 1.82 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 52.17 Mn
Mar 31, 2026 20.69 Mn
Dec 31, 2025 2.97 Mn
Sep 30, 2025 1.89 Mn
Jun 30, 2025 -236,000.00
Mar 31, 2025 241,000.00
Dec 31, 2024 21,000.00
Sep 30, 2024 -56,000.00
Jun 30, 2024 -297,000.00
Mar 31, 2024 -10,000.00
Dec 31, 2023 -130,000.00
Sep 30, 2023 -158,000.00
Jun 30, 2023 70,000.00
Mar 31, 2023 324,000.00
Dec 31, 2022 506,000.00
Sep 30, 2022 15.15 Mn
Jun 30, 2022 1.10 Mn
Mar 31, 2022 3.82 Mn
Dec 31, 2021 797,000.00
Sep 30, 2021 2.36 Mn